Canada Markets closed

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05330.0000 (0.00%)
At close: 03:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.0533
Open0.0533
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0533 - 0.0533
52 Week Range0.0510 - 0.2666
Volume10,001
Avg. Volume5,191
Market Cap8.229M
Beta (5Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line

    VANCOUVER, BC / ACCESSWIRE / November 30, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that is has successfully completed the R&D of a newly developed effervescent functional mushroom tablet product for online sales in Europe and North America.

  • CNW Group

    NeutriSci Provides Production Update and Partner Progress

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to provide the following update.

  • ACCESSWIRE

    NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner

    VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has received an additional order from Tabletz LLC.